Skip to main content
. 2024 Dec 30;29:636. doi: 10.1186/s40001-024-02252-1

Table 2.

Outcomes for the study cohort

control group (n = 38) observation group (n = 38) P
Daily duration spent on executing the AW-PP (minutes), mean ± SD 4.64 ± 1.02 2.74 ± 0.86  < 0.001
Daily total AW-PP (hours),mean ± SD 6.03 ± 0.66 8.52 ± 1.01  < 0.001
Daily duration until the first position adjustment (minutes), mean ± SD 36.57 ± 8.69 59.89 ± 12.73  < 0.001
Daily frequency of position adjustments during the AW-PP(n),mean ± SD 17.95 ± 2.58 11.03 ± 2.67  < 0.001
daily number of hours under HFNO (hours),mean ± SD 4.34 ± 1.08 3.88 ± 1.16 0.122
daily number of hours under NIV (hours),mean ± SD 4.98 ± 0.66 5.60 ± 1.15 0.175
Escalated to NIV (n),% 9 (33.3) 7 (21.9) 0.324
Hospital LOS(days),mean ± SD 19.13 ± 4.70 17.84 ± 5.97 0.299
Intubation, n (%) 11 (28.9) 9 (23.7) 0.602
mortality, n (%) 6 (15.8) 4 (10.5) 0.497
Adverse events
  Kinking NIRS circuit,n (%) 23 (60.5) 5 (13.2)  < 0.001
  Pain, n (%) 21 (55.3) 7 (18.4) 0.001
  Shortness of breath,n (%) 9 (23.7) 2 (5.3) 0.022
 Dizziness, n (%) 5 (13.2) 0 (0) 0.021
  Pressure ulcers, n (%) 26 (68.4) 7 (18.4)  < 0.001
Stage
 I, n (%) 18 (47.4) 6 (15.8) 0.003
 II, n (%) 8 (21.1) 1 (2.6) 0.013
Site
 Face, n (%) 12 (31.6) 3 (7.9) 0.009
 Chest, n (%) 21 (55.3) 5 (13.2)  < 0.001
 Knee, n (%) 7 (18.4) 1 (2.6) 0.025
 Other, n (%) 2 (5.3) 0 (0) 0.152

AW-PP awake prone positioning, HFNO High-flow Nasal Oxygen, NIV Non-invasive ventilation, LOS length of stay, NIRS non-invasive respiratory support